176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.56%
Revenue growth above 1.5x INTC's 1.15%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.96%
Gross profit growth above 1.5x INTC's 1.72%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
15.72%
Positive EBIT growth while INTC is negative. John Neff might see a substantial edge in operational management.
15.72%
Positive operating income growth while INTC is negative. John Neff might view this as a competitive edge in operations.
23.74%
Net income growth above 1.5x INTC's 10.37%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
30.00%
EPS growth above 1.5x INTC's 13.24%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
26.00%
Diluted EPS growth above 1.5x INTC's 12.12%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-2.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.94%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.79%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
146.87%
OCF growth above 1.5x INTC's 1.37%. David Dodd would confirm a clear edge in underlying cash generation.
169.29%
FCF growth above 1.5x INTC's 8.87%. David Dodd would verify if the firm’s strategic investments yield superior returns.
106.56%
Similar 10Y revenue/share CAGR to INTC's 102.45%. Walter Schloss might see both firms benefiting from the same long-term demand.
124.91%
5Y revenue/share CAGR above 1.5x INTC's 61.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
32.49%
3Y revenue/share CAGR above 1.5x INTC's 12.76%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
36087.01%
10Y OCF/share CAGR above 1.5x INTC's 85.12%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2009.64%
5Y OCF/share CAGR above 1.5x INTC's 96.32%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-5.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
418.14%
Net income/share CAGR above 1.5x INTC's 127.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
194.09%
5Y net income/share CAGR above 1.5x INTC's 85.83%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-12.16%
Negative 3Y CAGR while INTC is 15.90%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
261.31%
10Y equity/share CAGR above 1.5x INTC's 91.14%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
76.00%
5Y equity/share CAGR 1.25-1.5x INTC's 55.16%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
43.76%
3Y equity/share CAGR 1.25-1.5x INTC's 29.44%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.75%
Firm’s AR is declining while INTC shows 21.39%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.96%
Inventory growth well above INTC's 3.84%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
26.96%
Asset growth above 1.5x INTC's 0.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.39%
BV/share growth above 1.5x INTC's 0.31%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
7974.49%
Debt growth far above INTC's 3.35%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-1.07%
Our R&D shrinks while INTC invests at 5.21%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
12.16%
SG&A growth well above INTC's 3.54%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.